ApoB is a blood test that counts the actual particles that cause plaque in your arteries. LDL-C only estimates the weight of cholesterol they carry. About 1 in 3 people have a normal LDL but a high ApoB, which means a standard cholesterol report can miss real heart risk.
Table of Contents
- Why Standard Lipid Panels Fall Short
- The Truck and Cargo Analogy
- The Discordance Gap: Where Heart Attacks Hide
- How We Lower ApoB: Functional and Pharmaceutical Tools
- Are You in the Discordance Gap?
- Common Questions
- Deep Questions
Why Standard Lipid Panels Fall Short
You go to your annual physical, get a basic cholesterol panel, and get a quick call back. "Your numbers look fine. Cut back on cheese. See you next year." You hang up relieved. You feel safe.
That moment is often where good preventive medicine fails without anyone noticing.
Most doctors still use LDL-C, which stands for low-density lipoprotein cholesterol. LDL-C measures the weight, or concentration, of cholesterol in your blood. It became standard in the 1970s because it was cheap and easy to estimate.
The problem is biology. The cells in your artery wall do not get damaged by the weight of cholesterol drifting by. They get damaged by the number of particles crashing into them, again and again, over years.
In Medicine 3.0, the model we follow at Fishtown Medicine, we measure ApoB, short for apolipoprotein B. ApoB counts the exact number of plaque-causing particles in your blood. Knowing your LDL without knowing your ApoB is like knowing the total weight of traffic on I-95 without knowing how many cars are on the road.
I have seen what happens when patients are told they are "safe" based only on LDL-C. I have cared for the heart attacks and strokes that should not have happened. That experience is why I do not rely on outdated metrics for the people I care for.
The Truck and Cargo Analogy
Atherosclerosis, the buildup of plaque inside artery walls, is driven by how often particles collide with the artery lining, not by how much cholesterol they happen to carry.
Picture your artery as the Schuylkill Expressway. Cholesterol is the cargo. The lipoprotein particles are the cars and trucks carrying it.
- LDL-C measures the total weight of the cargo.
- ApoB measures the number of vehicles.
What causes a traffic jam in your arteries? Not the weight of the passengers. The number of vehicles on the road. If you have 1,000 passengers in 1,000 small cars, the road is jammed. If those same 1,000 passengers ride in 20 buses, the road is clear.
Standard medicine measures the passengers. We measure the cars. ApoB is the car count.
The Discordance Gap: Where Heart Attacks Hide
If LDL-C and ApoB always told the same story, the test you ordered would not matter. They do not always tell the same story. In an estimated 20 to 50% of people, the 2 values are discordant, meaning they disagree.
The dangerous version looks like this:
- Normal LDL-C, high ApoB. Your standard panel says "fine." Your particle count says "not fine." This pattern shows up most often in people with insulin resistance (when cells respond poorly to insulin), high triglycerides, or central body fat.
This describes a large slice of busy professionals across Philadelphia who eat on the run, sit through long meetings, and sleep less than they should. We use ApoB to find the people hiding in this gap.
You can read more about how this connects to overall metabolic patterns in our guide on metabolic health.
How We Lower ApoB: Functional and Pharmaceutical Tools
Once we know your ApoB number, the plan is rarely "eat more oatmeal." We build a layered strategy that uses food, supplements, and medications based on how high the number is and what is driving it.
| Mechanism | Functional Tools | Pharmaceutical Tools |
|---|---|---|
| Pull more particles out of the blood | Soluble fiber (psyllium husk) binds bile acids in the gut, so the liver pulls more LDL and ApoB out of the blood to make new bile. | Statins block the livers main cholesterol-making enzyme. The liver responds by pulling more particles out of the blood. |
| Block absorption | Plant sterols compete with cholesterol for absorption in the gut. | Ezetimibe specifically blocks cholesterol absorption in the small intestine. |
| Boost LDL receptor activity | Berberine can mildly increase the LDL receptors that pull particles out of the blood. | PCSK9 inhibitors (a monthly injection) protect those receptors and can lower ApoB by more than half. |
| Slow particle production | Red yeast rice contains monacolin K, a natural statin-like compound. | Bempedoic acid acts on the same pathway as statins but only in the liver, which can avoid muscle side effects. |
Fishtown Medicine
A 90-minute conversation with Dr. Ash. A written plan you can actually follow.
For mild elevations or someone newly tuning their diet, we often start with food and fiber. For people with strong genetic patterns or existing plaque, we move quickly to medications, because biology will outpace lifestyle on its own.
Guidance from the Clinic

Patients often ask, "Why was this not part of my old labs?"
It usually takes about 17 years for solid evidence to become standard practice. ApoB is the better marker, but the broader system is slow to update. We do not wait for that to change. We give you the data and the agency to act on the best available science today.
I treat ApoB with the seriousness of a cancer screening result. We want it low. The targets I generally use:
- Low risk: under 80 mg/dL.
- Optimal: under 60 mg/dL.
- Reversal range (for people with known plaque): under 40 mg/dL.
Are You in the Discordance Gap?
Use this short list to see if your "normal" cholesterol may be hiding real risk.
- Belly weight or a waist over 35 inches (women) or 40 inches (men)?
- Triglycerides over 100 mg/dL?
- Fasting insulin over 8 microIU/mL?
- Family history of heart attack or stroke before age 60?
- Diagnosed with pre-diabetes or metabolic syndrome?
- High-carb or high-saturated-fat eating pattern?
- Told your "ratios look fine" without ApoB ever being mentioned?
If you checked 2 or more boxes, your standard panel may be falsely reassuring. An ApoB test can reveal what is actually happening.
Actionable Steps in Philly
Your next move is simple. Stop guessing. Get the right number.
- Request the test: Ask for ApoB specifically at your next blood draw. Most labs can add it for around $15 to $20. If your current practice will not order it, we are happy to.
- Audit saturated fat: A diet heavy in butter, fatty meat, and tropical oils raises ApoB in many people. Lean toward olive oil, nuts, avocado, and fatty fish.
- Add soluble fiber: Beans, lentils, oats, and a serving of psyllium husk in the morning can drop ApoB by roughly 5 to 10% on their own.
- Walk after meals: A 10 to 15 minute walk after eating helps lower triglycerides, which often travel with high ApoB.
- Check your family history: Early heart disease in a parent or sibling is a strong reason to test ApoB and lipoprotein(a) at least once.
We use ApoB as our north star for heart health. Count the cars, not the cargo.
If you are in the Philadelphia area and want to stop guessing about your cardiovascular risk, book a Warm Invitation Call and we will look at your data together.
Key Takeaways
- ApoB counts particles. LDL-C estimates weight. Particles cause plaque, so ApoB is the better signal.
- 20 to 50% of people are discordant. Their LDL looks fine, but their ApoB is high.
- Insulin resistance and central body fat are the most common reasons LDL underestimates risk.
- Lower targets matter. Under 80 mg/dL for low risk, under 60 mg/dL for optimal, under 40 mg/dL for plaque reversal.
- The test is cheap. Around $15 to $20 at most major labs.
Scientific References
- Sniderman AD, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.
- Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41(1):111-188.
- Marcovina S, et al. Effect of discordance between low-density lipoprotein cholesterol and particle number on coronary artery disease. Am J Cardiol. 2007.
- Ference BA, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Evidence from genetic, epidemiologic, and clinical studies. Eur Heart J. 2017;38(32):2459-2472.

Fishtown Medicine | Articles
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
Dr. Ash reads every intake himself, and answers questions personally - usually within a few hours.




